Heat Biologics Inc Shares Fall 3.6% Below Previous 52-Week Low - Market Mover
The shares fell 3.6% lower than its previous 52-week low of $3.30, with trading volume higher than its 30 day average
Dec 30, 2021 by Kwhen Finance Editors
Heat Biologics Inc (HTBX) shares closed 3.6% lower than its previous 52 week low, giving the company a market cap of $83M. The stock is currently down 38.4% year-to-date, down 41.1% over the past 12 months, and down 94.7% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%.
Trading Activity
- Trading volume this week was 53.5% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Heat Biologics Inc | -3.6 | -38.4 | -41.1 | -80.8 | -1.2 |
| Dow Jones Industrial Average | 0.2 | 21.0 | 21.8 | -0.3 | 23.9 |
| S&P 500 Index | 0.1 | 29.2 | 29.8 | -0.4 | 32.5 |
| Health Care | 0.6 | 23.0 | 24.6 | -0.8 | 26.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -218.4%
- The company's stock price performance over the past 12 months lags the peer average by -225.4%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Heat Biologics Inc | HTBX | 0 | -38.4 | -41.1 | -80.8 | -1.2 |
| Peer Avg | N/A | -94.5 | 32.5 | 32.7 | -28.5 | 61.1 |
| Pfizer Inc. | PFE | 17.0 | 63.8 | 63.7 | -6.8 | 77.2 |
| Lilly(Eli) & Co | LLY | 44.3 | 66.2 | 68.5 | -2.8 | 73.1 |
| Bristol-Myers Squibb Co. | BMY | -25.6 | 2.9 | 5.2 | -10.1 | 16.9 |
| Xencor Inc | XNCR | -576.3 | -6.9 | -11.6 | -30.7 | 34.3 |
| Celldex Therapeutics Inc. | CLDX | -26.3 | 132.6 | 132.9 | -29.1 | 163.8 |
| Onconova Therapeutics Inc | ONTX | 0 | -63.8 | -62.4 | -91.3 | 1.2 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: